About 86,600,000 results
Open links in new tab
  1. AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR ...

    Nov 7, 2025 · Parkinsonism: AUSTEDO XR and AUSTEDO may cause parkinsonism in patients with Huntington’s disease or tardive dyskinesia. Parkinsonism has also been observed with …

  2. Teva Presents First Real-World Data from the IMPACT-TD Registry …

    Jun 1, 2024 · The two-part IMPACT-TD study is a 3-year longitudinal observational study evaluating how TD progresses over time and impacts a patient’s quality of life (Part A), as well …

  3. Teva Real-World Study Finds AUSTEDO and AUSTEDO XR

    Nov 10, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia …

  4. Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO

    Nov 7, 2025 · Teva Pharmaceuticals presented new findings from the IMPACT-TD Registry indicating that treatment with AUSTEDO and AUSTEDO XR significantly improved the lives of …

  5. Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia …

    Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.

  6. 94% Movement Improvement: Teva's AUSTEDO XR Transforms Life

    Sep 21, 2025 · Beyond the physical symptom improvements, the data demonstrates AUSTEDO XR's impact on quality of life metrics, with over 77% of patients reporting increased comfort in …

  7. Study Explores Tardive Dyskinesia Outcomes With …

    Nov 12, 2024 · The two-part IMPACT-TD study is a 3-year longitudinal observational study evaluating how TD progresses and impacts a patient’s quality of life, as well as outcomes …

  8. AUSTEDO tablets and AUSTEDO XR extended-release tablets

    Nov 8, 2025 · AUSTEDO tablets or AUSTEDO XR led to reductions in the severity of involuntary movements and improvements in patient-reported quality of life.

  9. Teva Unveils Real-World Data from IMPACT-TD Study at Psych …

    Jun 13, 2024 · The study is divided into two parts: Part A focuses on the progression of TD and its impact on patients' quality of life over time, while Part B evaluates outcomes related to …

  10. Austedo XR Shows Symptom Improvement for Patients | Teva

    Sep 20, 2025 · Patients taking Austedo XR report symptom improvement and better quality of life in real-world settings.